Nolan Townsend

Company: LEXEO Therapeutics

Job title: Chief Executive Officer

Seminars:

Emergence of Cardiac Precision Medicine & Perspectives on the Future 9:00 am

Entering a new era of cardiac drug development to move past the ‘one size fits all’, historic approaches to treating cardiac diseases Breaking down the genetic components of cardiovascular disease and addressing the transition from small molecules to genetic medicines which may offer a functional cure Why will this space see a significant growth in…Read more

day: Conference Day 2